Industry News
Arsenic found in many US red wines, but health risks depend on total diet
9/30/2015
A new University of Washington study that tested 65 wines from America's top four wine-producing states -- California, Washington, New York and Oregon -- found all but one have arsenic levels that...
Underdetection, not overdiagnosis, is the real problem in breast cancer screening
9/30/2015
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis...
Disguising drugs as platelets could make them more effective against cancer
9/30/2015
Researchers have found that coating anticancer drugs in platelet membranes allows them to last longer in the body and target a range of different cancer cells.
Risk factors for prostate cancer
9/30/2015
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency...
Study lays groundwork for blood test to aid in the detection and monitoring of myeloma
9/30/2015
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma.
UCLA researchers have created an effective program to improve the likelihood of colorectal cancer screenings among first-degree relatives of colorectal cancer survivors.
Scientists pioneer 3-D-printed drug delivering micro-needles
9/30/2015
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery.
Risk factors for prostate cancer
9/30/2015
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency...
Novartis has announced results of a Phase III pivotal study showing Afinitor® (everolimus) tablets reduced the risk of progression by 52% (hazard ratio [HR] = 0.
Primary care doctors are ill-prepared to deal with growing demand for cancer care
9/30/2015
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners (RCGP) annual congress in Glasgow, UK (Oct 1-3) that primary care doctors will not be...